<p>The levels of plasma and CSF IL-21 in individual subjects were tested by ELISA. (A) The levels of plasma IL-21 in the HC, MS patients pre- and post-treatment. (B) The levels of plasma IL-21 in the MS-CR patients pre- and post- treatment. (C) The levels of plasma IL-21 in the MS-PR patients pre- and post- treatment. (D) The levels of CSF IL-21 in the MS patients pre-treatment and NND patients. Data are expressed as the mean values of individual samples. The horizontal lines represented the median values.</p
Multiple Sclerosis (MS) is a neuroinflammatory disease of the central nervous system (CNS) in which ...
BackgroundMultiple sclerosis (MS) is a chronic, progressive autoimmune disease of the central nervou...
<p>The data are presented as box plots with whiskers, showing the median with the upper (75) and low...
<p>Comparison of TGF-β (A), IL-6 (B), IL-23 (C) cytokines concentrations between HC, RRMS patients i...
<p>(A-B) The numbers of ICOS+ and CCR7+ICOS+ memory Tfh cells were positively associated with the ED...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Studying multiple sclerosis (MS) and its treatments requires the use of biomarkers for underlying pa...
Studying multiple sclerosis (MS) and its treatments requires the use of biomarkers for underlying pa...
Studying multiple sclerosis (MS) and its treatments requires the use of biomarkers for underlying pa...
Abstract Studying multiple sclerosis (MS) and its treatments requires the use of biomarkers for un...
<p>(A) Average IL-6 levels in patients with the three indicated IL-6 genotypes. (B) Average IL-6 lev...
Abstract Studying multiple sclerosis (MS) and its treatments requires the use of biomarkers for un...
Reliable, and easy to measure, immunological markers able to denote disease characteristics in multi...
Multiple Sclerosis (MS) is a neuroinflammatory disease of the central nervous system (CNS) in which ...
Multiple Sclerosis (MS) is a neuroinflammatory disease of the central nervous system (CNS) in which ...
BackgroundMultiple sclerosis (MS) is a chronic, progressive autoimmune disease of the central nervou...
<p>The data are presented as box plots with whiskers, showing the median with the upper (75) and low...
<p>Comparison of TGF-β (A), IL-6 (B), IL-23 (C) cytokines concentrations between HC, RRMS patients i...
<p>(A-B) The numbers of ICOS+ and CCR7+ICOS+ memory Tfh cells were positively associated with the ED...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Studying multiple sclerosis (MS) and its treatments requires the use of biomarkers for underlying pa...
Studying multiple sclerosis (MS) and its treatments requires the use of biomarkers for underlying pa...
Studying multiple sclerosis (MS) and its treatments requires the use of biomarkers for underlying pa...
Abstract Studying multiple sclerosis (MS) and its treatments requires the use of biomarkers for un...
<p>(A) Average IL-6 levels in patients with the three indicated IL-6 genotypes. (B) Average IL-6 lev...
Abstract Studying multiple sclerosis (MS) and its treatments requires the use of biomarkers for un...
Reliable, and easy to measure, immunological markers able to denote disease characteristics in multi...
Multiple Sclerosis (MS) is a neuroinflammatory disease of the central nervous system (CNS) in which ...
Multiple Sclerosis (MS) is a neuroinflammatory disease of the central nervous system (CNS) in which ...
BackgroundMultiple sclerosis (MS) is a chronic, progressive autoimmune disease of the central nervou...
<p>The data are presented as box plots with whiskers, showing the median with the upper (75) and low...